Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(20%)
Results Posted
40%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
5
50%
Ph early_phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Recruiting2
Withdrawn1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
83.3%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

completed550%
recruiting220%
withdrawn110%
not_yet_recruiting110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10